<span style="color: #222222;">Secretary Pharmaceuticals S. Aparna has said that growing at an accelerated pace in pandemic times and projected to become a 65 billion dollar industry by 2024, the medical devices sector offers a big opportunity for domestic players, especially engineering MSMEs to make deep inroads into global markets. </span><br />'' <br />'' <span style="color: #222222;">Speaking at the inaugural session of Medical Devices Expo 2021, Ms. Aparna emphasized that innovation, adoption and adaptation of new technologies would be key to tap the huge opportunities in both domestic and export markets. </span><br />'' <br />'' <span style="color: #222222;">She noted that the medical devices industry which is growing at a Compound Annual Growth Rate CAGR of close to 15 per cent holds the highest growth potential among all the constituents of the healthcare sector ranging from pharma, hospital services etc. </span><br />'' <br />'' <span style="color: #222222;">The Secretary said, it is important to remember that this is an interdisciplinary sector with a huge range of products covering reagents, diagnostic kits, high-end imaging equipment and therefore it is a sector that requires a very nuanced approach. Ms Aparna also highlighted the critical need for integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy-to- navigate interface between investors, manufactures, exporters and the regulatory eco-system.</span>
News On AIR | March 25, 2021 6:53 PM
Innovation, adoption and adaptation of new technologies would be key to tap huge opportunities, says Secretary Pharmaceuticals